When a serious illness meets a refusal of residence in France, the situation feels impossible: the treatment is here, the doctors are here, yet the préfecture (local immigration authority) has just refused the titre de séjour (residence permit) and attached an OQTF (order to leave French territory) giving thirty days to depart. French law provides a specific answer for this exact situation — the residence permit for seriously ill foreign nationals, commonly called the étranger malade (sick foreigner) permit — but it is granted only under strict cumulative conditions, and it turns almost entirely on a medical opinion issued by the OFII (French Office for Immigration and Integration) that neither the applicant nor the préfet (prefect, the State representative who decides) writes. This guide explains who qualifies, how the medical procedure works, why refusals happen, and how the administrative courts review them, drawing on the statute as in force in 2026 and on five recent rulings including a February 2026 decision of the Conseil d’État (Council of State, France’s highest administrative court).
Two warnings before starting. First, the medical permit is a one-year temporary card, and every renewal re-examines the medical situation from scratch: holding the card for several years never guarantees the next renewal. Second, the refusal almost always comes with an OQTF whose challenge deadline is short and is not extended by writing polite letters to the administration. Anyone receiving such a decision should have the full file — refusal, OQTF, and OFII opinion — reviewed by an immigration lawyer in Paris handling residence permit refusals and OQTF appeals without waiting for the departure period to expire.
I. The medical residence permit: three cumulative conditions and a decisive medical opinion
A. Habitual residence, exceptionally serious consequences and no effective treatment in the country of origin
The legal basis is Article L.425-9 of the CESEDA (Code on the Entry and Residence of Foreign Nationals and the Right of Asylum), which provides: “L’étranger, résidant habituellement en France, dont l’état de santé nécessite une prise en charge médicale dont le défaut pourrait avoir pour lui des conséquences d’une exceptionnelle gravité et qui, eu égard à l’offre de soins et aux caractéristiques du système de santé dans le pays dont il est originaire, ne pourrait pas y bénéficier effectivement d’un traitement approprié, se voit délivrer une carte de séjour temporaire portant la mention ” vie privée et familiale ” d’une durée d’un an.” In plain English: a foreign national habitually residing in France whose state of health requires medical care, whose absence could have consequences of exceptional gravity for them, and who could not effectively receive appropriate treatment in their country of origin given that country’s healthcare provision and health system, is issued a one-year temporary residence card marked vie privée et familiale (private and family life).
Three points in that single sentence decide most cases. First, habitual residence in France must be shown — utility bills, tax notices, proof of work such as self-employed (auto-entrepreneur) registration, school certificates for children, and any prior permits all count. In a May 2026 ruling, the Marseille administrative court of appeal annulled a refusal precisely because the préfet had wrongly denied habitual residence even though the applicant proved regular self-employed activity in France since January 2023 (CAA Marseille, 13 May 2026, No. 25MA01059). Second, the lack of care must threaten consequences of “exceptional gravity” — a high threshold that goes well beyond showing a genuine or chronic illness. An applicant suffering from rheumatoid spondyloarthritis and type 2 diabetes, however real and deserving of regular follow-up those conditions were, lost his case in Paris in April 2026 because the decisive question was not the reality of the illness but whether the statutory test was met on all three prongs (CAA Paris, 30 April 2026, No. 25PA04826). By contrast, post-traumatic stress combined with severe depression carrying suicidal risk, treated with high-dose antipsychotic and anxiolytic medication, was accepted as engaging the vital prognosis in the case that reached the Conseil d’État in February 2026 (CE, 2 February 2026, No. 502417).
Third, the applicant must show that they could not effectively receive appropriate treatment back home, assessed against the actual healthcare provision and the characteristics of that country’s health system — not in the abstract, but effectively, for them. Cost, geographic availability, continuity of highly specialised follow-up, and the reliability of supply chains for specific medicines all matter here, and documentary evidence about the real conditions of access to care in the country concerned is essential. Two clarifications from the case law deserve attention. A Moroccan applicant who argued that, isolated and without resources, she could not afford the indispensable medical follow-up and medication in her country of origin saw her claim rejected on the facts, which shows that assertions about cost must be documented, not merely stated (CAA Toulouse, 1 October 2024, No. 23TL01713). And for a refugee recognised by another State, the comparison country is not the country of origin at all: in its February 2026 decision, the Conseil d’État held that where a refugee recognised by Greece applies in France, availability must be assessed against the Greek health system, and it added that the Minister could not rely on any presumption that appropriate treatment is available in other European Union Member States. Each file therefore stands or falls on concrete, up-to-date medical and country evidence.
Two structural advantages soften this demanding test. No long-stay visa is required: the statute expressly provides that the condition of Article L.412-1 of the CESEDA (first issuance subject to producing a long-stay visa) cannot be raised against the applicant, so even unlawful entry does not by itself defeat the claim. And the protection extends to removal itself: the shield of Article L.611-3, 9° of the CESEDA, recalled by the Toulouse court in July 2025, provides that “Ne peuvent faire l’objet d’une décision portant obligation de quitter le territoire français : (…) 9° L’étranger résidant habituellement en France si son état de santé nécessite une prise en charge médicale dont le défaut pourrait avoir pour lui des conséquences d’une exceptionnelle gravité”, that is, a foreign national in this medical situation cannot lawfully be served with an OQTF at all (CAA Toulouse, 3 July 2025, No. 23TL02223). Where the medical test is genuinely met, both the refusal and the removal order fall together.
B. The OFII medical board: how the decisive opinion is produced and how judges use it
The préfet does not assess the illness. Under Article R.425-11 of the CESEDA, “le préfet délivre la carte de séjour temporaire portant la mention ” vie privée et familiale ” au vu d’un avis émis par un collège de médecins à compétence nationale de l’Office français de l’immigration et de l’intégration”, meaning the permit is issued in light of an opinion from a national-level board of OFII doctors. That opinion is prepared on two pillars: a medical report drawn up by an OFII doctor from the certificate of the applicant’s usual treating doctor or a hospital practitioner, and the available information on the possibility of effectively receiving appropriate treatment in the country of origin. The board itself is composed of three doctors under Article R.425-13 of the CESEDA — the doctor who wrote the report does not sit on it — and it may deliberate by telephone or video conference.
The content of the opinion is standardised by the order (arrêté) of 27 December 2016: the board must state (a) whether the applicant’s health requires medical care, (b) whether the absence of that care could have consequences of exceptional gravity, (c) whether, given the healthcare provision and health system of the country of origin, the applicant could effectively receive appropriate treatment there, and (d) the foreseeable duration of treatment — adding, where treatment is deemed available, whether the applicant’s health allows travel there without risk. The opinion is signed by all three doctors. In the April 2026 Paris case, the applicant attacked the opinion’s regularity, but the court verified that the 6 November 2023 opinion followed the official model and held that the mere absence of any mention of treatment duration — information whose purpose is to indicate whether long-term care is needed where the applicant otherwise qualifies — was not capable of tainting the opinion’s regularity. Procedural challenges to the opinion therefore succeed only on real irregularities, not on formal omissions without consequence.
How much weight does this opinion carry before the judge? The rule was restated twice in 2026. A favourable OFII opinion creates a factual presumption in the applicant’s favour: as the Marseille court put it in April 2024, “la partie qui justifie d’un avis du collège des médecins du service médical de l’Office français de l’immigration et de l’intégration (OFII) qui lui est favorable doit être regardée comme apportant des éléments de fait susceptibles de faire présumer l’existence ou l’absence d’un état de santé de nature à justifier la délivrance ou le refus d’un titre de séjour” the existence of a qualifying health condition, and it is then for the other party, with full respect for medical secrecy, to produce evidence allowing the court to assess the situation (CAA Marseille, 15 April 2024, No. 23MA01692). Conversely, an unfavourable opinion is not the end of the story. The Conseil d’État held in February 2026 that “il appartient au juge administratif de prendre en considération l’avis médical rendu par le collège des médecins de l’OFII”, which means the judge must take the OFII opinion into consideration — not that the judge is bound by it. An applicant who wishes to contest the opinion’s conclusion must lift the medical secrecy covering their own information, so that the judge can rule on all the relevant material, including the complete medical-report file on which the board relied, and the judge may — without being obliged to — seek the observations of the OFII. In that case the Bordeaux court of appeal had set aside an unfavourable OFII opinion on the basis of the medical certificates produced in debate and the medical file disclosed at its request, and the Conseil d’État confirmed that approach, rejecting the Minister’s appeal with €3,000 in costs. The practical lesson is direct: never accept an unfavourable OFII opinion as final without assembling contrary certificates from treating specialists, hospital reports, and up-to-date country-of-care documentation, and be prepared to authorise disclosure of the full OFII medical file to the court.
II. Challenging the refusal and the OQTF: errors to look for, remedies and deadlines
A. Reading the refusal like a judge: factual errors, prior permits and the removal order
Most refusals challenged in court fail — the Paris, Toulouse and Marseille rejections of 2024–2026 surveyed above confirm that judges apply the three statutory conditions strictly. But refusals built on factual mistakes are annulled, and the May 2026 Marseille annulment is the model of what to look for. The Georgian applicant in that case had entered France on a visa to join his French husband, had held a spouse’s permit, had seen the 2021 refusal annulled by the Nice administrative tribunal with an order to issue a permit, had held the medical permit from March 2022 to March 2023, and had applied for renewal — yet the 28 June 2024 refusal claimed irregular entry, no application and unlawful presence, no habitual residence, and unproven exceptional gravity, even though the attached OFII opinion of 5 September 2023 itself recognised HIV infection treated with Biktarvy requiring care whose absence could have exceptionally serious consequences. The court found that the préfet had, in the words of CAA Marseille, 13 May 2026, No. 25MA01059, “a, ainsi que le soutient M. D…, commis de multiples erreurs de fait pour refuser de délivrer au requérant le titre de séjour sollicité, lesquelles révèlent un défaut d’examen sérieux de son dossier” — committed multiple errors of fact revealing a failure to examine the file seriously — annulled both the tribunal judgment and the refusal with its thirty-day OQTF, ordered re-examination within one month with an autorisation provisoire de séjour (temporary waiting permit) in the meantime, and awarded €1,500 in costs.
Four checks therefore belong in every file review. First, compare each ground of the refusal against the documents actually in the file: wrong dates, ignored permits, misread visas, and contradictions between the refusal’s reasoning and the OFII opinion it relies on are the classic annulment material. Second, a change of outcome between two identical medical situations must be explained — the Paris applicant argued that his condition had not changed since the years he obtained permits, and while that argument alone did not win, unexplained reversals combined with other errors strengthen a manifest-error plea. Third, verify whether the OQTF could lawfully be issued at all: if the three medical conditions are met, Article L.611-3, 9° protects against the removal order itself, and the OQTF falls with the refusal since it was issued on the ground of Article L.611-1 of the CESEDA (refusal of issuance or renewal of a permit). Fourth, remember that a refusal of the medical permit does not automatically mean removal is possible: as the Toulouse court recalled, a refusal of residence does not by itself imply return to the country of origin, and each decision — stay, removal, destination country, voluntary-departure period — must be challenged on its own grounds.
Applicants who do not meet the medical test should immediately consider the two fallback permits pleaded, unsuccessfully on the facts but correctly in law, in the 2024–2026 cases. Article L.423-23 of the CESEDA grants a one-year vie privée et familiale card, again without the long-stay visa requirement, where refusal of residence would disproportionately infringe the right to respect for private and family life — the Moroccan applicant in the October 2024 Toulouse case combined it with Article 8 of the European Convention on Human Rights, relying on her husband and son in France. And Article L.435-1 of the CESEDA allows admission on humanitarian grounds or for exceptional reasons (admission exceptionnelle au séjour) with a card marked salarié (employee), travailleur temporaire (temporary worker) or vie privée et familiale, also without the visa condition — the Paris applicant invoked it as a subsidiary basis. These routes require their own evidence (family ties, integration, employment, length of presence), and they should be raised before the tribunal alongside the medical claim, not discovered after the appeal deadline has passed. Structuring the whole strategy early, with an immigration lawyer in Paris experienced in medical residence cases and tribunal litigation, is what separates files that survive from files that expire.
B. Appeals, injunctions and time limits: acting before the clock runs out
Procedure first, because it is where the most rights are lost. A refusal of a residence permit alone is challenged before the administrative tribunal within two months of notification — the English-language service-public.fr guidance confirms a two-month window to bring the case before the administrative judge running from notification or publication of the contested decision (service-public.fr, residence permit for medical reasons). But where, as is standard, the refusal is accompanied by an OQTF with a thirty-day voluntary-departure period, the whole package — removal order, stay decision, departure-period decision and any entry ban — is challenged together under Article L.614-1 of the CESEDA, and Article R.614-3 of the CESEDA sends those challenges to the time limits of Article R.911-1 of the CESEDA: the tribunal must be seized within one month of notification, it rules within six months, and — decisive detail — filing an administrative appeal (recours gracieux to the préfet or recours hiérarchique to the Minister) does not extend the court deadline. Letters to the administration never replace a timely tribunal application, and the one-month period runs from notification of the order, not from any later response.
What can the tribunal be asked to do? Annulment of the refusal and of the OQTF is the core claim, supported by the pleas described above: procedural defects in the OFII opinion process, errors of fact, manifest error in assessing gravity or treatment availability, breach of Article L.611-3, 9°, and infringement of Article 8 where family life is at stake. Beyond annulment, always seek an injunction: the courts that annul order the préfet to re-examine the application — within one month with an autorisation provisoire de séjour in the Marseille annulment, within three months with the same interim protection in the Bordeaux case confirmed by the Conseil d’État — and an astreinte (penalty per day of delay) can be requested where the administration has a record of inertia. Costs follow success under Article L.761-1 of the administrative justice code (€1,500 in Marseille, €3,000 at the Conseil d’État level), and applicants of limited means should apply for aide juridictionnelle (legal aid) immediately, as the applicants in the Paris and Marseille cases did. Note the honest limit the Marseille court stated: annulment for defective examination implies re-examination, not necessarily issuance — the renewed procedure must still apply the three medical conditions correctly, this time on a complete and accurately read file.
A final practical checklist for the weeks after a refusal. Obtain the full OFII opinion and the complete medical-report file without delay, since every plea depends on what the board actually wrote. Gather fresh specialist certificates describing the current treatment, its dosage, and precisely what interruption would cause, plus dated evidence on the effective availability — or unavailability — of that exact treatment in the relevant country, whether the country of origin or, for refugees recognised elsewhere, the country of refuge. Assemble proof of habitual residence and family ties in parallel, so the fallback claims under Articles L.423-23 and L.435-1 are ready from day one. Calendar the tribunal deadline from the notification date and file within it even if an administrative appeal is also lodged. And keep every prior permit, tribunal judgment and récépissé (receipt for a pending application): as the Marseille annulment shows, the administration sometimes forgets its own decisions, and the applicant’s file is the only reliable memory.
Conclusion
The étranger malade permit is demanding but real: one-year vie privée et familiale cards are issued every year to applicants who prove habitual residence, exceptionally grave consequences of interrupted care, and the absence of effective treatment in the relevant country — without any long-stay visa requirement. The OFII board’s opinion dominates the procedure, yet it is an opinion, not a verdict: the Conseil d’État‘s February 2026 ruling confirms that judges must consider it without being bound by it, provided applicants lift medical secrecy and bring complete contrary evidence. Refusals deserve a rigorous, fast review, because factual errors and defective examinations still lead to annulment with re-examination and interim residence, as the May 2026 Marseille ruling demonstrates — while unfounded challenges are firmly rejected, with their OQTF intact. In this field more than most, the file decides the outcome, and the deadline decides whether the file is ever read.